{"acquisitions":[],"changes":[],"country":"US","description":"Insilico Medicine uses generative AI to design novel drug candidates, predict clinical trial outcomes, and accelerate hit-to-lead optimization for pharma partners and its own pipeline. Its end-to-end platform covers target discovery, molecular design, and synthesis planning, moving its lead fibrosis compound into Phase II trials.","domain":"insilico.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":"insilico","githubStars":12,"industry":"unknown","industrySources":[],"investors":[],"lat":42.365635,"lng":-71.104002,"location":"Cambridge MA","multiples":[],"name":"Insilico Medicine","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":110000000,"connectionsAmong":[],"currency":"USD","date":"2025-03-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"insilico-com-2025-03-01-series-e","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"insilico-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"insilico.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://insilico.com"},{"fact":"description","publisher":"insilico.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://insilico.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Tilda","reCAPTCHA","PHP","DDoS-Guard","Hammer.js"],"totalRaisedUsd":110000000,"traction":[],"updatedAt":"2026-05-05","valuations":[]}